# Amniotic Fluid Tandem Mass Spectrometry for Pregnancies Complicated by NIH and Severe Symmetrical IUGR

> **NCT00143039** · — · TERMINATED · sponsor: **Obstetrix Medical Group** · enrollment: 48 (actual)

## Conditions studied

- Hydrops Fetalis
- Fetal Growth Retardation

## Interventions

- **PROCEDURE:** Tandem MS test for inborn errors of metabolism

## Key facts

- **NCT ID:** NCT00143039
- **Lead sponsor:** Obstetrix Medical Group
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** TERMINATED
- **Start date:** 2006-03
- **Primary completion:** 2009-08
- **Final completion:** 2009-08
- **Target enrollment:** 48 (ACTUAL)
- **Why stopped:** No metabolic disordered ID'd by TMS in either control/test group at \>50%enrolled
- **Last updated:** 2014-12-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00143039

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00143039, "Amniotic Fluid Tandem Mass Spectrometry for Pregnancies Complicated by NIH and Severe Symmetrical IUGR". Retrieved via AI Analytics 2026-08-21 from https://api.ai-analytics.org/clinical/NCT00143039. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*